Table 1. Median and 95% confidence interval (CI) estimates of the rate of change of marginal effect of benzene exposure below 1 ppm (/ – see equations (9) and (12)) and above 1 ppm (/ - see equations (10) and (13)) and the change in absolute rate of change of the marginal effects from below 1 ppm to above 1 ppm (/ – see equations (11) and (14)) for the first two principal components of the Acute Myeloid Leukemia pathway and six chosen genes of interest.
/βg,1 | /βg,2 | /δg | ||||
Pathway/Gene | Median | 95% CI | Median | 95% CI | Median | 95% CI |
Acute Myeloid Leukemia: Principal Component 1 | 0.333 | (0.008, 0.394) | −0.006 | (−0.016, 0.002) | 0.328 | (0.019, 0.380) |
Acute Myeloid Leukemia: Principal Component 2 | 0.106 | (−0.244,0.349) | −0.024 | (−0.040,0.010) | 0.108 | (−0.012,0.353) |
RUNX1 | 0.07 | (0.018, 0.158) | 0.004 | (−0.008, 0.025) | 0.063 | (0.010, 0.151) |
FLT3 | −0.079 | (−0.204, −0.012) | 0 | (−0.005, 0.004) | 0.078 | (0.011, 0.202) |
CEBPA | −0.877 | (−1.11, −0.584) | 0.03 | (0.006, 0.069) | 0.847 | (0.561, 1.068) |
LEF1 | 0.032 | (−0.035, 0.120) | −0.009 | (−0.019, −0.002) | 0.025 | (−0.008, 0.106) |
CYP2E1 | 0.051 | (−0.004, 0.147) | −0.002 | (−0.007, 0.002) | 0.049 | (0.002, 0.146) |
CYP2F1 | 0.002 | (−0.033, 0.03) | −0.001 | (−0.004, 0.001) | 0.008 | (−0.001, 0.038) |